UniProtKB/Swiss-Prot Q96CV9: Variant p.Arg545Gln

Optineurin
Gene: OPTN
Feedback?

Variant information Variant position:

545 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Glutamine (Q) at position 545 (R545Q, p.Arg545Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In GLC1E; uncertain significance. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs75654767 [ dbSNP | Ensembl ]

Sequence information Variant position:

545 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

577 The length of the canonical sequence.
Location on the sequence:

TSDSDQQAYLVQRGAEDRDW R QQRNIPIHSCPKCGEVLPDI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TS-DSDQQAYLVQRGAEDRDW---RQQRNIPIHSCPKCGEVLPDI

Rhesus macaque                TS-DPDQQAYLVQRGTEDRDW---QQQRNIPIHSCPKCGEV

Mouse                         TS-DSDQQTYLFQRGAEDRSWQHGQQPRSIPIHSCPKCGEV

Rat                           TS-DSDQQAYLFQRGAEDMSWQHGQQPRSIPIHSCPKCGEV

Pig                           AS-DADQQAFLVQRGAEDRNWLQ-QQQQNIPIHSCPKCGEV

Chicken                       AP-DREHSPRLVQRGTGSQEW---PEQRNISIYSCPKCEEI

Xenopus laevis                SLLDASEGPYLVARGAANM------EQPSITVYTCPKCNLT

Zebrafish                     GA-NPQGPTAPNNLPGGRGEW----QQQNIPDHACPKCGEV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 577	Optineurin
Region	411 – 577	Interaction with HD
Binding site	555 – 555
Binding site	558 – 558
Modified residue	526 – 526	Phosphoserine

Literature citations
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
Rezaie T.; Child A.; Hitchings R.; Brice G.; Miller L.; Coca-Prados M.; Heon E.; Krupin T.; Ritch R.; Kreutzer D.; Crick R.P.; Sarfarazi M.;
Science 295:1077-1079(2002)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); FUNCTION; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; VARIANTS GLC1E LYS-50 AND GLN-545; VARIANTS LYS-98; SER-201; HIS-213; ARG-216 AND PRO-357; Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.
Alward W.L.M.; Kwon Y.H.; Kawase K.; Craig J.E.; Hayreh S.S.; Johnson A.T.; Khanna C.L.; Yamamoto T.; Mackey D.A.; Roos B.R.; Affatigato L.M.; Sheffield V.C.; Stone E.M.;
Am. J. Ophthalmol. 136:904-910(2003)
Cited for: VARIANT GLC1E GLN-545; Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma.
Funayama T.; Ishikawa K.; Ohtake Y.; Tanino T.; Kurosaka D.; Kimura I.; Suzuki K.; Ideta H.; Nakamoto K.; Yasuda N.; Fujimaki T.; Murakami A.; Asaoka R.; Hotta Y.; Tanihara H.; Kanamoto T.; Mishima H.; Fukuchi T.; Abe H.; Iwata T.; Shimada N.; Kudoh J.; Shimizu N.; Mashima Y.;
Invest. Ophthalmol. Vis. Sci. 45:4359-4367(2004)
Cited for: VARIANTS GLC1E ASP-26 AND GLN-545; VARIANT LYS-98;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.